Loading...

Pranab Barman

Title(s)Assistant Clinical Professor, Medicine
SchoolHealth Sciences
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Barman PM, Patel YA. Getting a "Grip" on Sarcopenia for the Liver Transplant Candidate: Time to Focus on Muscle Function. Liver Transpl. 2019 Oct; 25(10):1475-1476. PMID: 31433898.
      View in: PubMed
    2. Parikh ND, Zhang P, Singal AG, Derstine BA, Krishnamurthy V, Barman P, Waljee AK, Su GL. Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization. Cancer Res Treat. 2018 Apr; 50(2):530-537. PMID: 28602057.
      View in: PubMed
    3. Sharma P, Parikh ND, Yu J, Barman P, Derstine BA, Sonnenday CJ, Wang SC, Su GL. Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients. Liver Transpl. 2016 08; 22(8):1092-8. PMID: 27064263.
      View in: PubMed
    4. Singal AG, Zhang P, Waljee AK, Ananthakrishnan L, Parikh ND, Sharma P, Barman P, Krishnamurthy V, Wang L, Wang SC, Su GL. Body Composition Features Predict Overall Survival in Patients With Hepatocellular Carcinoma. Clin Transl Gastroenterol. 2016 May 26; 7:e172. PMID: 27228403.
      View in: PubMed
    5. Barman PM, Su GL. Limitations of the barcelona clinic liver cancer staging system with a focus on transarterial chemoembolization as a key modality for treatment of hepatocellular carcinoma. Clin Liver Dis (Hoboken). 2016 Feb; 7(2):32-35. PMID: 31041024.
      View in: PubMed
    6. Willatt J, Hannawa KK, Ruma JA, Frankel TL, Owen D, Barman PM. Image-guided therapies in the treatment of hepatocellular carcinoma: A multidisciplinary perspective. World J Hepatol. 2015 Feb 27; 7(2):235-44. PMID: 25729478.
      View in: PubMed
    7. Barman PM, Sharma P, Krishnamurthy V, Willatt J, McCurdy H, Moseley RH, Su GL. Predictors of mortality in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Dig Dis Sci. 2014 Nov; 59(11):2821-5. PMID: 24973040.
      View in: PubMed
    8. Sharma P, Barman P. Everolimus for liver transplant recipients: is it ready for prime time? Gastroenterology. 2013 Feb; 144(2):459-61. PMID: 23260492.
      View in: PubMed